Leerink Partnrs Brokers Increase Earnings Estimates for CGEM
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Free Report) - Equities researchers at Leerink Partnrs upped their FY2026 earnings estimates for Cullinan Therapeutics in a research report issued on Monday, October 27th. Leerink Partnrs analyst A. Berens now expects that the company will post earnings per

What's Your Reaction?











